Ohcanbohtosat - Mathurin Fumery
- Čájehuvvo 1 - 20 / 57
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A meta-analysis of observational studies Dahkki Mathurin Fuméry, Xiaocang Cao, Luc Dauchet, Corinne Gower‐Rousseau, Laurent Peyrin‐Biroulet, Jean–Frédéric Colombel
Almmustuhtton 2013Revisão -
9
-
10
Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy Dahkki Mathurin Fumery, Parambir S. Dulai, Paul Meirick, Ann Farrell, Sonia Ramamoorthy, William J. Sandborn, Siddharth Singh
Almmustuhtton 2016Revisão -
11
-
12
Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis Dahkki Mathurin Fuméry, Parambir S. Dulai, Samir Gupta, Larry J. Prokop, Sonia Ramamoorthy, William J. Sandborn, Siddharth Singh
Almmustuhtton 2016Revisão -
13
Systematic review with meta‐analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases Dahkki Siddharth Singh, Parambir S. Dulai, Niels Vande Casteele, Robert Battat, Mathurin Fuméry, Brigid S. Boland, William J. Sandborn
Almmustuhtton 2019Revisão -
14
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses Dahkki Nghia Nguyen, Mathurin Fuméry, Parambir S. Dulai, Larry J. Prokop, William J. Sandborn, M. Hassan Murad, Siddharth Singh
Almmustuhtton 2018Revisão -
15
No Benefit of Concomitant Immunomodulator Therapy on Efficacy of Biologics That Are Not Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases: A Meta-analy... Dahkki Clara Yzet, Momar Diouf, Siddarth Singh, Franck Brazier, Justine Turpin, Éric Nguyen-Khac, Jonathan Meynier, Mathurin Fuméry
Almmustuhtton 2020Revisão -
16
No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials Dahkki Siddharth Singh, J. Proudfoot, Parambir S. Dulai, Vipul Jairath, Mathurin Fuméry, Ronghui Xu, Brian G. Feagan, William J. Sandborn
Almmustuhtton 2018Revisão -
17
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis Dahkki Siddharth Singh, M. Hassan Murad, Mathurin Fuméry, Rocío Sedaño, Vipul Jairath, Remo Panaccione, William J. Sandborn, Christopher Ma
Almmustuhtton 2021Revisão -
18
Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Anal... Dahkki Siddharth Singh, Mathurin Fuméry, Abha Singh, Namrata Singh, Larry J. Prokop, Parambir S. Dulai, William J. Sandborn, Jeffrey R. Curtis
Almmustuhtton 2019Revisão -
19
Young Adult Patients With Paediatric‐Onset Inflammatory Bowel Disease Have a Higher Educational Level and a Higher Employment Rate Than the General Population Dahkki Hélène Sarter, Mathilde Le Coniac, Ariane Leroyer, Guillaume Savoye, Mathurin Fuméry, Nathalie Guillon, Corinne Gower‐Rousseau, Delphine Ley, Dominique Turck
Almmustuhtton 2025Artigo -
20
Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn’s Disease Dahkki Clara Yzet, Momar Diouf, Jean‐Philippe Le Mouel, Franck Brazier, Justine Turpin, Julien Loreau, Jean Louis Dupas, Laurent Peyrin–Biroulet, Mathurin Fuméry
Almmustuhtton 2019Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Internal medicine
Disease
Gastroenterology
Crohn's disease
Surgery
Inflammatory bowel disease
Ulcerative colitis
Cohort
Environmental health
Meta-analysis
Population
Infliximab
Physics
Cohort study
Pediatrics
Cancer
Inflammatory Bowel Diseases
MEDLINE
Pathology
Ustekinumab
Vedolizumab
Adverse effect
Colorectal cancer
Intensive care medicine
Law
Political science
Randomized controlled trial
Tumor necrosis factor alpha
Incidence (geometry)